Pam Taub
University of California, San Diego · UC San Diego Health · University of California, San Diego Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pam Taub as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:37 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07203196 · Circadian Health Regulation and Optimization for Rejuvenation OutcomesSalk Institute for Biological Studies · active not recruiting · Aging, Healthy, Blood Sugar; High, Blood Sugar (Glucose) Control · principal investigator
- Ph2NCT07189234 · Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic HealthUniversity of California, San Diego · recruiting · Metabolic Syndrome, Pre-diabetes · principal investigator
- Ph1NCT06884059 · Time Restricted Eating in Patients With MicroalbuminuriaUniversity of California, San Diego · recruiting · Type 2 Diabetes Mellitus (T2DM), Time Restricted Eating, Microalbuminuria · principal investigator
- Ph4NCT06865885 · LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL LoweringUniversity of California, San Diego · recruiting · Drug Interactions, Primary Prevention, Cardiometabolic Syndrome · principal investigator
- Ph2NCT06305780 · RECOVER-AUTONOMIC Platform ProtocolKanecia Obie Zimmerman · completed · Long COVID, Long Covid19, Long Covid-19 · study chair
- Ph2NCT06305806 · RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)Kanecia Obie Zimmerman · completed · Long COVID, Long Covid19, Long Covid-19 · study chair
- Ph2NCT06305793 · RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)Kanecia Obie Zimmerman · completed · Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19 · study chair
- N/ANCT05409651 · Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.University of California, San Diego · unknown · Postural Tachycardia Syndrome · principal investigator
- N/ANCT05365529 · Time-Restricted Eating for Type II Diabetes: TRE-T2DUniversity of California, San Diego · active not recruiting · Diabetes Mellitus, Type 2, Time Restricted Feeding, Diabetes type2 · principal investigator
- N/ANCT04057339 · The Influence of Time-Restricted Eating in Patients With Metabolic SyndromeUniversity of California, San Diego · completed · Metabolic Syndrome, Pre-Diabetes · principal investigator
- N/ANCT03533023 · The Healthy Heroes StudyUniversity of California, San Diego · completed · Shift Workers' Health, Time Restricted Eating, Fasting · principal investigator
- Ph3NCT03182725 · Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia SyndromeUniversity of California, San Diego · completed · Postural Orthostatic Tachycardia Syndrome · principal investigator
- N/ANCT03182985 · The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic SyndromeUniversity of California, San Diego · completed · Weight Loss, Metabolic Syndrome, Overweight and Obesity · principal investigator
- N/ANCT02490527 · Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise CapacityUniversity of California, San Diego · completed · Statin Intolerance · principal investigator
- N/ANCT01671514 · Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and FunctionUniversity of California, San Diego · completed · Heart Failure, Type 2 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic SyndromeR01DK118278 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2018 to 2026 · $845,622 awarded in 2026Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:37 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.Cell Metab · 2020724 citationsRCR 37.1
- Feasibility of time-restricted eating and impacts on cardiometabolic health in 24-h shift workers: The Healthy Heroes randomized control trial.Cell Metab · 2022168 citationsRCR 14.5
- Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.J Am Coll Cardiol · 202196 citationsRCR 6.5
- Primary results of the HABIT Trial (heart failure assessment with BNP in the home).J Am Coll Cardiol · 201374 citationsRCR 2.4
- (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients.Int J Cardiol · 201373 citationsRCR 2.8
- Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial.Ann Intern Med · 202455 citationsRCR 10.3
- 50 citationsRCR 2.3
- 49 citationsRCR 2.3
- Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (-)-epicatechin in healthy volunteers.Food Funct · 201532 citationsRCR 1.5
- Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure.Int J Mol Sci · 202032 citationsRCR 1.7